Protein component could be added to COVID vaccines to protect against new variants - study
While most available COVID-19 vaccines target the virus' spike protein, variants including Delta and Omicron have mutations that affect this protein, making them harder for immune cells to detect.
A medical worker carries RT-PCR swab tests at a pre-departure coronavirus disease (COVID-19) testing facility, as countries react to the new coronavirus Omicron variant, outside the international terminal at Sydney Airport in Sydney, Australia, November 29, 2021.(photo credit: REUTERS/LOREN ELLIOT/FILE PHOTO)ByJERUSALEM POST STAFFUpdated:
